{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:29:55Z","timestamp":1790422195302,"version":"4.1.0"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6,1]]},"DOI":"10.1097\/qai.0b013e3181daafd5","type":"journal-article","created":{"date-parts":[[2010,4,8]],"date-time":"2010-04-08T02:52:30Z","timestamp":1270695150000},"page":"122-128","source":"Crossref","is-referenced-by-count":26,"title":["Risk Factors of Isolated Antibody Against Core Antigen of Hepatitis B Virus: Association With HIV Infection and Age but not Hepatitis C Virus Infection"],"prefix":"10.1097","volume":"54","author":[{"given":"Shiou-Haur","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Jui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan Shin-Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan-Chen","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Kai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Hsu","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chou-Ping","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiun-Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsing-Chun","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiun-Nong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chi","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsi-Hsun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210131","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/1096-9071(200012)62:4<450::AID-JMV9>3.0.CO;2-Y","article-title":"Serological pattern anti-HBc alone: report on a workshop.","volume":"62","author":"Grob","year":"2000","journal-title":"J Med Virol"},{"key":"R2-3-20210131","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000025026","article-title":"High frequency of HCV infection in individuals with isolated antibody to hepatitis B core antigen.","volume":"43","author":"Berger","year":"2000","journal-title":"Intervirology"},{"key":"R3-3-20210131","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/clinids\/23.1.189","article-title":"The significance of isolated antibody to hepatitis B core antigen seropositivity in patients infected with human immunodeficiency virus.","volume":"23","author":"Davaro","year":"1996","journal-title":"Clin Infect Dis"},{"key":"R4-3-20210131","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0168-8278(02)00019-3","article-title":"The evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients.","volume":"36","author":"Piroth","year":"2002","journal-title":"J Hepatol"},{"key":"R5-3-20210131","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1086\/375084","article-title":"Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals.","volume":"36","author":"Gandhi","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R7-3-20210131","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1468-1293.2004.00206.x","article-title":"Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients.","volume":"5","author":"Neau","year":"2004","journal-title":"HIV Med"},{"key":"R8-3-20210131","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1086\/515578","article-title":"Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women.","volume":"195","author":"French","year":"2007","journal-title":"J Infect Dis"},{"key":"R9-3-20210131","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1128\/JCM.19.4.521-525.1984","article-title":"Epidemiological analysis of the significance of low-positive test results for antibody to hepatitis B surface and core antigens.","volume":"19","author":"Hadler","year":"1984","journal-title":"J Clin Microbiol"},{"key":"R10-3-20210131","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1046\/j.1537-2995.1989.29389162729.x","article-title":"American Red Cross experience with routine testing for hepatitis B core antibody.","volume":"29","author":"AuBuchon","year":"1989","journal-title":"Transfusion"},{"key":"R11-3-20210131","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0168-8278(05)80407-6","article-title":"Detection of HBs antigen in anti-HBc alone positive sera.","volume":"21","author":"Joller-Jemelka","year":"1994","journal-title":"J Hepatol"},{"key":"R12-3-20210131","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0168-8278(95)80305-X","article-title":"Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus.","volume":"23","author":"Jilg","year":"1995","journal-title":"J Hepatol"},{"key":"R13-3-20210131","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1046\/j.1469-0691.2000.00160.x","article-title":"Isolated antibody to hepatitis B core is associated with hepatitis C virus co-infection.","volume":"6","author":"Greub","year":"2000","journal-title":"Clin Microbiol Infect"},{"key":"R14-3-20210131","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1469-0691.2004.00771.x","article-title":"Isolated anti-HBV core phenotype in anti-HCV-positive patients is associated with hepatitis C virus replication.","volume":"10","author":"Wedemeyer","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"R15-3-20210131","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/hep.510310134","article-title":"Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C.","volume":"31","author":"Wiedmann","year":"2000","journal-title":"Hepatology"},{"key":"R16-3-20210131","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/jhep.2001.25172","article-title":"Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely occult?","volume":"34","author":"Brechot","year":"2001","journal-title":"Hepatology"},{"key":"R17-3-20210131","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1086\/522173","article-title":"Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.","volume":"45","author":"Sheng","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R18-3-20210131","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(81)90585-7","article-title":"Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan.","volume":"2","author":"Beasley","year":"1981","journal-title":"Lancet"},{"key":"R19-3-20210131","doi-asserted-by":"crossref","first-page":"796","DOI":"10.7326\/0003-4819-135-9-200111060-00009","article-title":"Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination.","volume":"135","author":"Ni","year":"2001","journal-title":"Ann Intern Med"},{"key":"R20-3-20210131","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/hep.1840130505","article-title":"Seroepidemiology of hepatitis C virus infection in Taiwan.","volume":"13","author":"Lee","year":"1991","journal-title":"Hepatology"},{"key":"R21-3-20210131","first-page":"55","article-title":"Prevalence of antibodies to hepatitis C virus (anti-HCV) in different populations in Taiwan.","volume":"24","author":"Wu","year":"1991","journal-title":"Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi"},{"key":"R22-3-20210131","first-page":"826","article-title":"Seroepidemiology of hepatitis C virus infection among drug abusers in southern Taiwan.","volume":"97","author":"Chang","year":"1998","journal-title":"J Formos Med Assoc"},{"key":"R23-3-20210131","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1023\/A:1007662315835","article-title":"Hepatitis C virus infection among short-term intravenous drug users in southern Taiwan.","volume":"15","author":"Chang","year":"1999","journal-title":"Eur J Epidemiol"},{"key":"R24-3-20210131","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000087269","article-title":"Combined interferon and ribavirin therapy for chronic hepatitis C in Taiwan.","volume":"49","author":"Lai","year":"2006","journal-title":"Intervirology"},{"key":"R25-3-20210131","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0929-6646(09)60231-X","article-title":"Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants.","volume":"106","author":"Chen","year":"2007","journal-title":"J Formos Med Assoc"},{"key":"R26-3-20210131","first-page":"53","article-title":"Update and projection on HIV\/AIDS in Taiwan. AIDS Educ.","volume":"16","author":"Twu","year":"2004","journal-title":"Prev"},{"key":"R27-3-20210131","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1053\/jhep.2001.25225","article-title":"Occult hepatitis B virus infection: a hidden menace?","volume":"34","author":"Conjeevaram","year":"2001","journal-title":"Hepatology"},{"key":"R28-3-20210131","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.1073\/pnas.0730819100","article-title":"Perturbations in B cell responsiveness to CD4+ T cell help in HIV-infected individuals.","volume":"100","author":"Moir","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R29-3-20210131","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/01.qai.0000214818.80539.da","article-title":"An epidemic of HIV type I CRF07_BC infection among injection drug users in Taiwan.","volume":"42","author":"Lin","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R30-3-20210131","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(07)60291-8","article-title":"HIV-1 in Taiwan.","volume":"369","author":"Chen","year":"2007","journal-title":"Lancet"},{"key":"R31-3-20210131","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1086\/587992","article-title":"Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.","volume":"46","author":"Liu","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R32-3-20210131","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0929-6646(08)60106-0","article-title":"Seroprevalence of viral hepatitis and sexually transmitted disease among adults with recently diagnosed HIV infection in Southern Taiwan, 2000-2005: upsurge in hepatitis C virus infections among injection drug users.","volume":"107","author":"Lee","year":"2008","journal-title":"J Formos Med Assoc"},{"key":"R33-3-20210131","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3748\/wjg.15.1237","article-title":"Clinical significance of anti-HBc alone in human immunodeficiency virus-positive patients.","volume":"15","author":"Perez-Rodriguez","year":"2009","journal-title":"World J Gastroenterol"},{"key":"R34-3-20210131","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.jhep.2005.11.004","article-title":"Epidemiology of viral hepatitis and HIV co-infection.","volume":"44","author":"Alter","year":"2006","journal-title":"J Hepatol"},{"key":"R35-3-20210131","doi-asserted-by":"crossref","first-page":"S138","DOI":"10.1002\/hep.22883","article-title":"Hepatitis B and human immunodeficiency virus coinfection.","volume":"49","author":"Thio","year":"2009","journal-title":"Hepatology"},{"issue":"Suppl 5","key":"R36-3-20210131","doi-asserted-by":"crossref","first-page":"S263","DOI":"10.1086\/427440","article-title":"Epidemiology and natural history of hepatitis C virus infection in injection drug users: implications for treatment.","volume":"40","author":"Sulkowski","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R37-3-20210131","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3748\/wjg.v12.i8.1255","article-title":"Serological pattern anti-HBc alone: characterization of 552 individuals and clinical significance.","volume":"12","author":"Knoll","year":"2006","journal-title":"World J Gastroenterol"},{"key":"R38-3-20210131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0749-3797(98)00003-8","article-title":"Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection.","volume":"15","author":"Averhoff","year":"1998","journal-title":"Am J Prev Med"},{"key":"R39-3-20210131","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJM199907013410104","article-title":"Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.","volume":"341","author":"Cacciola","year":"1999","journal-title":"N Engl J Med"},{"key":"R40-3-20210131","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1111\/j.1572-0241.2000.03371.x","article-title":"The impact of previous HBV infection on the course of chronic hepatitis C.","volume":"95","author":"De Maria","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"R41-3-20210131","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF01584356","article-title":"Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study.","volume":"17","author":"Hofer","year":"1998","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R42-3-20210131","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1097\/00002030-200210180-00024","article-title":"Lack of occult hepatitis B virus infection in HIV-infected patients.","volume":"16","author":"Nunez","year":"2002","journal-title":"AIDS"},{"key":"R43-3-20210131","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00126334-200312010-00013","article-title":"Low prevalence of ongoing hepatitis B viremia in HIV-positive individuals with isolated antibody to hepatitis B core antigen.","volume":"34","author":"Gandhi","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R44-3-20210131","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00002030-200402200-00028","article-title":"Serological pattern anti-hepatitis B core alone in HIV or hepatitis C virus-infected patients is not fully explained by hepatitis B surface antigen mutants.","volume":"18","author":"Wagner","year":"2004","journal-title":"AIDS"},{"key":"R45-3-20210131","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1086\/427882","article-title":"Occult hepatitis B virus infection in HIV-infected patients with isolated antibodies to hepatitis B core antigen: Aquitaine cohort, 2002-2003.","volume":"40","author":"Neau","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R46-3-20210131","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1086\/520989","article-title":"Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women.","volume":"45","author":"Tsui","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R47-3-20210131","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1053\/j.gastro.2007.02.055","article-title":"Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies.","volume":"132","author":"Ni","year":"2007","journal-title":"Gastroenterology"},{"key":"R48-3-20210131","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1001\/jama.1987.03390190075023","article-title":"A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers.","volume":"257","author":"Chen","year":"1987","journal-title":"JAMA"},{"key":"R49-3-20210131","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/epirev\/mxj010","article-title":"Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched.","volume":"28","author":"Chien","year":"2006","journal-title":"Epidemiol Rev"},{"key":"R50-3-20210131","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/ajg.2008.159","article-title":"Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination.","volume":"104","author":"Sun","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R51-3-20210131","first-page":"200","article-title":"Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital.","volume":"41","author":"Liang","year":"2008","journal-title":"J Microbiol Immunol Infect"},{"key":"R52-3-20210131","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jama.284.4.450","article-title":"The natural history of hepatitis C virus infection: host, viral, and environmental factors.","volume":"284","author":"Thomas","year":"2000","journal-title":"JAMA"},{"key":"R53-3-20210131","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00705-009-0559-6","article-title":"The underlying mechanisms for the anti-HBc alone serological profile.","volume":"155","author":"Ponde","year":"2010","journal-title":"Arch Virol"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00126334-201006010-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:18:27Z","timestamp":1786040307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-201006010-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,1]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3181daafd5","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6,1]]}}}